Fruquintinib Maintenance Therapy After Adjuvant Chemotherapy in NED Advanced CRC Patients: A Phase II Study
This is a prospective, single-arm, phase II study aimed at exploring the clinical efficacy and safety of fruquintinib as maintenance therapy for advanced CRC patients who achieve NED after adjuvant chemotherapy.
原文地址: https://www.cveoy.top/t/topic/fwv5 著作权归作者所有。请勿转载和采集!